Screener
Insight Molecular Diagnostics Inc. IMDX Q2 2026 earnings
Reported August 10, 2026 · After market close
Revenue$239.0KMiss by $198.5K
EPS-$0.31Miss by $0.06
Revenue estimate$437.5K
EPS estimate-$0.25
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$215.1K
EPS estimate-$0.23
Valuation & ratios
Segments
By geography
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Insight Molecular Diagnostics Inc. report Q2 2026 earnings?
- Insight Molecular Diagnostics Inc. (IMDX) reported Q2 2026 earnings on August 10, 2026 after market close.
- What were Insight Molecular Diagnostics Inc.'s Q2 2026 revenue and EPS?
- Insight Molecular Diagnostics Inc. reported revenue of $239.0K and eps of $-0.31 for Q2 2026.
- Did Insight Molecular Diagnostics Inc. beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $437.5K by $198.5K. EPS missed the consensus estimate of $-0.25 by $0.06.
- How did Insight Molecular Diagnostics Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 53.9% from $518.0K a year earlier and eps declined 3.3% from $-0.30.
- Where can I find Insight Molecular Diagnostics Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-036863) and the 10-Q periodic report (0001642380-26-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.
